• News
  • SAN DIEGO
  • Medical

Vical licenses vaccine technology to Cyvax

Vical Inc. (Nasdaq: VICL) said Wednesday that it licensed its Vaxfectin technology, which is designed to make vaccines more effective, to a company that intends to use it in malaria vaccines.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!